Brian Longstreet is a top-level Global Biotech Senior Executive and Visionary Leader having held Senior Leadership roles in the US & EU with a tremendous track record of experience and results. He has broad, diverse experience in both large Pharma and smaller Biotech start-up environments and extensive therapeutic background knowledge in areas including Immunology, Oncology, Infectious Diseases, & Vaccines. Adept at R&D, Regulatory, and Corporate Planning with a strong focus on science and execution. A well-rounded Business Strategist with U.S. and Global P&L experience who excels in building, producing, and sustaining long term results in the Biopharma industry. Brian built his career foundation in large Pharma (Schering-Plough, Merck & Co) and over the past 9 years has been focused on building and growing small-to-medium sized Biopharma organizations. He has an undergraduate degree in Economics from the University of Pennsylvania’s Wharton School of Business.
Brian is very excited about the creation of Exolvo Biosciences and became involved with the venture based on the huge potential and game changing aspects of the technology for many different stakeholders including patients, doctors, and payers. It is essentially the ‘holy grail’ of drug delivery.
